Cancer Prevention Pharmaceuticals Employment Compensation Letter to Eugene Gerner, Ph.D.
Cancer Prevention Pharmaceuticals (CPP) and Eugene Gerner, Ph.D., have agreed that, effective February 1, 2014, Dr. Gerner will serve as Chief Scientific Officer on a half-time basis with an annual salary of $120,000. This amount is equivalent to a full-time salary of $240,000 per year. The letter confirms the salary adjustment and Dr. Gerner's continued employment with CPP.
Exhibit 10.10
January 13, 2014
Gene Gerner
Dear Gene:
I am pleased to inform you that, effective February 1, 2014, your employment with CPP as its Chief Scientific Officer on a halftime employee basis will reflect an increase in salary to $120,000 per year (equivalent to a full-time salary of $240,000 per year).
Thank you for your exemplary contributions to CPP. I look forward to achieving great things together at Cancer Prevention Pharmaceuticals!
| Sincerely, | |
| /s/Jeffrey Jacob | |
| Jeffrey Jacob | |
| CEO |
Agreed to and Accepted by:
| /s/ Eugene Gerner | 2/1/2014 | |
| Eugene Gerner, Ph.D. | Date |
